focus
Previous article:
How to save PrEP access — and even expand it
Next article: STAT Readout: Today's biotech news includes Sana and Amylyx
Next article: STAT Readout: Today's biotech news includes Sana and Amylyx
hotspot
hotspot
-
Neurocrine congenital adrenal hyperplasia trial succeeds
2025-09-28 22:36 -
PBMs drew scrutiny in House hearing — and so did pharma
2025-09-28 22:12 -
STAT Readout: Today's biotech news includes Sana and Amylyx
2025-09-28 22:10 -
Readout LOUD podcast: Merger Mondays, Ozempic panic
2025-09-28 21:53 -
Takeaways from AdvaMed, the largest medical devices conference
2025-09-28 21:02 -
How should state employee insurance handle Wegovy?
2025-09-28 20:43